We are live on ! Find out more
PAWC

P.A.W. Capital Portfolio holdings

AUM $131M
1-Year Est. Return 46.14%
This Fund
S&P 500
This Quarter Est. Return
+13.15%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$119M
AUM Growth
+$5.47M
Cap. Flow
-$409K
Cap. Flow %
-0.34%
Top 10 Hldgs %
42.35%
Holding
75
New
10
Increased
14
Reduced
13
Closed
11

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$2.6M
2
DXC icon
DXC Technology
DXC
+$2.14M
3
GAME icon
GameSquare
GAME
+$1.8M
4
RCM
R1 RCM Inc. Common Stock
RCM
+$1.21M
5
POL.WS
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
+$1.03M

Top Sells

Rank Stock Value
1
ZIXI
Zix Corporation
ZIXI
+$4.53M
2
PLBY icon
Playboy Inc
PLBY
+$2.53M
3
EMKR
Emcore Corp
EMKR
+$1.74M
4
QURE icon
uniQure
QURE
+$1.01M
5
CTLP
Cantaloupe
CTLP
+$938K

Sector Composition

Rank Sector Weight
1 Technology 29.93%
2 Healthcare 20.34%
3 Communication Services 18.42%
4 Industrials 7.45%
5 Consumer Staples 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APPS icon
1
Digital Turbine
APPS
$975M
$7.6M 6.38%
100,000
– –
MGNI icon
2
Magnite
MGNI
$2.76B
$7.11M 5.97%
210,000
+10,000
+5% +$339K
CCLD icon
3
CareCloud
CCLD
$104M
$5.51M 4.62%
654,000
+44,000
+7% +$366K
EVER icon
4
EverQuote
EVER
$892M
$5.39M 4.53%
165,000
– –
AMBA icon
5
Ambarella
AMBA
$3.77B
$5.12M 4.3%
48,000
– –
ALLT icon
6
Allot
ALLT
$372M
$4.96M 4.16%
250,000
-15,000
-6% -$276K
ASUR icon
7
Asure Software
ASUR
$232M
$3.81M 3.2%
430,000
-10,000
-2% -$82K
HYRE
8
DELISTED
HyreCar Inc. Common Stock
HYRE
$3.77M 3.16%
180,000
-20,000
-10% -$307K
GAIA icon
9
Gaia
GAIA
$46.8M
$3.63M 3.04%
330,000
+30,000
+10% +$340K
RCM
10
DELISTED
R1 RCM Inc. Common Stock
RCM
$3.56M 2.99%
160,000
+50,000
+45% +$1.21M
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.41M 2.86%
13,333
+666
+5% +$166K
PLBY icon
12
Playboy Inc
PLBY
$128M
$3.11M 2.61%
80,000
-60,000
-43% -$2.53M
CTLP
13
DELISTED
Cantaloupe
CTLP
$2.61M 2.19%
220,000
-80,000
-27% -$938K
IOVA icon
14
Iovance Biotherapeutics
IOVA
$1.82B
$2.6M 2.18%
+100,000
New +$2.6M
EMKR
15
DELISTED
Emcore Corp
EMKR
$2.44M 2.05%
26,500
-21,500
-45% -$1.74M
DXC icon
16
DXC Technology
DXC
$1.82B
$2.34M 1.96%
+60,000
New +$2.14M
APTO
17
DELISTED
Aptose Biosciences, Inc.
APTO
$2.32M 1.95%
1,556
+23
+2% +$50.1K
OPRX icon
18
OptimizeRx
OPRX
$114M
$2.17M 1.82%
35,000
-5,000
-13% -$254K
RTB
19
RTB Digital
RTB
$214M
$2.03M 1.7%
486
+57
+13% +$240K
EVRI
20
CALL
DELISTED
Everi Holdings
EVRI
$2M 1.67%
+80,000
New +$1.51M
CCCC icon
21
C4 Therapeutics
CCCC
$385M
$1.89M 1.59%
50,000
– –
GAME icon
22
GameSquare
GAME
$34.6M
$1.87M 1.57%
+39,583
New +$1.8M
ASPU
23
DELISTED
ASPEN GROUP, INC.
ASPU
$1.83M 1.53%
280,000
+30,000
+12% +$171K
MCHX icon
24
Marchex
MCHX
$76.2M
$1.8M 1.52%
590,000
-10,000
-2% -$27.9K
VRNS icon
25
Varonis Systems
VRNS
$4.59B
$1.73M 1.45%
30,000
– –
1
2 3

Similar funds

EIM
Emmett Investment Management New York $131M AUM 25.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
LC
LTG Capital Newton, Massachusetts $131M AUM 19.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
OIM
Oder Investment Management Woodland Hills, California $130M AUM 25.54% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $130M AUM

P.A.W. Capital's Q2 2021 Portfolio in Review

As of Q2 2021, P.A.W. Capital held 75 positions worth $119M, up 4.8% from $114M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

P.A.W. Capital's Q2 2021 filing shows 10 new, 14 increased, 13 reduced and 11 closed positions. Its largest new stake was Iovance Biotherapeutics: 100,000 shares worth $2.6M. The largest sale was Zix Corporation, an estimated $4.53M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

  • P.A.W. Capital's largest Q2 2021 buy was Iovance Biotherapeutics: 100,000 shares worth $2.6M.
  • P.A.W. Capital added most to R1 RCM Inc. Common Stock in Q2 2021, an estimated $1.21M increase.
  • P.A.W. Capital's biggest Q2 2021 reduction was Playboy Inc, cutting an estimated $2.53M.
  • P.A.W. Capital fully exited Zix Corporation in Q2 2021, selling an estimated $4.53M.
  • P.A.W. Capital's ten largest holdings make up 42% of its $119M portfolio in Q2 2021.
  • P.A.W. Capital opened 10 new positions and closed 11 in Q2 2021.
  • P.A.W. Capital's portfolio value rose 4.8% quarter-over-quarter to $119M.

Based on P.A.W. Capital's 13F filing for Q2 2021, filed 5 Aug 2021.